Pharmacy Medical News about Liver

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Epidemiology of Idiosyncratic Drug-Induced Liver Injury
Seminars in Liver Disease, 10/15/09

Bell LN et al. – Idiosyncratic drug–induced liver injury (DILI) is a significant health problem because of its unpredictable nature, poorly understood pathogenesis, and potential to cause fatal outcomes. It is also a significant hurdle for drug development and marketing of safe prescription medications. Idiosyncratic DILI is generally rare, but its occurrence is likely underappreciated due to the lack of active reporting or surveillance systems and substantial challenges involved in its recognition and diagnosis.

<< Previous
Inhibition of HIV-1 gene expression by Ciclopirox and...

Next >>
Septic pulmonary emboli secondary to disseminated,...

Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation
Liver Transplantation, 10/30/09 Relevance Score: 95%

Liver Regeneration in 120 Consecutive Living-Related Liver Donors
Transplantation Proceedings, 11/05/09 Relevance Score: 94%

A knowledge-based technique for liver segmentation in CT data
Computerized Medical Imaging and Graphics, 10/27/09 Relevance Score: 93%

Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09 Relevance Score: 93%

Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09 Relevance Score: 93%